Docmorris Ag Stock Revenue

DOCM Stock   5.24  0.07  1.35%   
As of the 3rd of March, DocMorris shows the Downside Deviation of 3.68, semi deviation of 3.28, and Mean Deviation of 2.7. DocMorris AG technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm DocMorris AG mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if DocMorris AG is priced favorably, providing market reflects its regular price of 5.24 per share.

DocMorris Total Revenue

1.08 Billion

DocMorris' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing DocMorris' valuation are provided below:
Gross Profit
230.3 M
Profit Margin
(0.11)
Market Capitalization
254.7 M
Enterprise Value Revenue
0.3119
Revenue
1.1 B
There are over one hundred nineteen available fundamental signals for DocMorris AG, which can be analyzed over time and compared to other ratios. All traders should should verify DocMorris' prevailing fundamental trends against the trends from 2010 to 2026 to make sure the company is sustainable. Enterprise Value is likely to climb to about 488.3 M in 2026, whereas Market Cap is likely to drop slightly above 257.4 M in 2026. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Total Revenue1.2 B1.1 B
At this time, DocMorris' Cost Of Revenue is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 0.02 in 2026, whereas Total Revenue is likely to drop slightly above 1.1 B in 2026.
  
The evolution of Revenue for DocMorris AG provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how DocMorris compares to historical norms and industry peers.

Latest DocMorris' Revenue Growth Pattern

Below is the plot of the Total Revenue of DocMorris AG over the last few years. Total revenue comprises all receipts DocMorris AG generated from the sale of its products or services. It is the total amount of income generated by the sale of goods or services related to the company's primary operations. DocMorris' Total Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in DocMorris' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 1.02 B10 Years Trend
Slightly volatile
   Total Revenue   
       Timeline  

DocMorris Revenue Regression Statistics

Arithmetic Mean997,256,166
Geometric Mean941,926,976
Coefficient Of Variation33.40
Mean Deviation241,214,901
Median969,462,000
Standard Deviation333,050,463
Sample Variance110922.6T
Range1.2B
R-Value0.63
Mean Square Error70762T
R-Squared0.40
Significance0.01
Slope41,813,438
Total Sum of Squares1774761.8T

DocMorris Revenue History

20261.1 B
20251.2 B
2024B
2023969.5 M
2022931 M
20211.7 B
20201.5 B

Historical and Projected quarterly revenue of DocMorris

Projected quarterly revenue analysis of DocMorris AG provides investors and stakeholders with an insight into the company's performance and growth prospects. When actual revenues of DocMorris match or exceed analyst estimates, it positively influences investor confidence and market perception, often leading to a rise in DocMorris' stock price.

DocMorris Revenue Driver Correlations

Understanding the fundamental principles of building solid financial models for DocMorris is extremely important. It helps to project a fair market value of DocMorris Stock properly, considering its historical fundamentals such as Revenue. Since DocMorris' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of DocMorris' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of DocMorris' interrelated accounts and indicators.
It's important to distinguish between DocMorris' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding DocMorris should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, DocMorris' market price signifies the transaction level at which participants voluntarily complete trades.

DocMorris 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to DocMorris' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of DocMorris.
0.00
12/03/2025
No Change 0.00  0.0 
In 3 months and 1 day
03/03/2026
0.00
If you would invest  0.00  in DocMorris on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding DocMorris AG or generate 0.0% return on investment in DocMorris over 90 days. DocMorris is related to or competes with IVF Hartmann, Coltene Holding, Newron Pharmaceuticals, Santhera Pharmaceuticals, Molecular Partners, Ascom Holding, and S H. DocMorris is entity of Switzerland. It is traded as Stock on SW exchange. More

DocMorris Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure DocMorris' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess DocMorris AG upside and downside potential and time the market with a certain degree of confidence.

DocMorris Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for DocMorris' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as DocMorris' standard deviation. In reality, there are many statistical measures that can use DocMorris historical prices to predict the future DocMorris' volatility.
Hype
Prediction
LowEstimatedHigh
1.335.249.15
Details
Intrinsic
Valuation
LowRealHigh
0.744.658.56
Details
Naive
Forecast
LowNextHigh
1.054.968.87
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.66-0.58-0.48
Details

DocMorris March 3, 2026 Technical Indicators

DocMorris AG Backtested Returns

At this stage we consider DocMorris Stock to be relatively risky. DocMorris AG secures Sharpe Ratio (or Efficiency) of close to zero, which denotes the company had a close to zero % return per unit of standard deviation over the last 3 months. We have found twenty-nine technical indicators for DocMorris AG, which you can use to evaluate the volatility of the firm. Please confirm DocMorris' Downside Deviation of 3.68, mean deviation of 2.7, and Semi Deviation of 3.28 to check if the risk estimate we provide is consistent with the expected return of 0.0259%. The firm shows a Beta (market volatility) of 0.52, which means possible diversification benefits within a given portfolio. As returns on the market increase, DocMorris' returns are expected to increase less than the market. However, during the bear market, the loss of holding DocMorris is expected to be smaller as well. DocMorris AG right now shows a risk of 3.91%. Please confirm DocMorris AG mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation , to decide if DocMorris AG will be following its price patterns.

Auto-correlation

    
  -0.58  

Good reverse predictability

DocMorris AG has good reverse predictability. Overlapping area represents the amount of predictability between DocMorris time series from 3rd of December 2025 to 17th of January 2026 and 17th of January 2026 to 3rd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of DocMorris AG price movement. The serial correlation of -0.58 indicates that roughly 58.0% of current DocMorris price fluctuation can be explain by its past prices.
Correlation Coefficient-0.58
Spearman Rank Test-0.55
Residual Average0.0
Price Variance0.09
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Competition

DocMorris Current Deferred Revenue

Current Deferred Revenue

420,612

At this time, DocMorris' Current Deferred Revenue is fairly stable compared to the past year.
Based on the latest financial disclosure, DocMorris AG reported 1.02 B of revenue. This is much higher than that of the Consumer Staples Distribution & Retail sector and significantly higher than that of the Consumer Staples industry. The revenue for all Switzerland stocks is notably lower than that of the firm.

DocMorris Revenue Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses DocMorris' direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of DocMorris could also be used in its relative valuation, which is a method of valuing DocMorris by comparing valuation metrics of similar companies.
DocMorris is currently under evaluation in revenue category among its peers.

DocMorris Fundamentals

About DocMorris Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze DocMorris AG's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DocMorris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DocMorris AG based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for DocMorris Stock Analysis

When running DocMorris' price analysis, check to measure DocMorris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy DocMorris is operating at the current time. Most of DocMorris' value examination focuses on studying past and present price action to predict the probability of DocMorris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move DocMorris' price. Additionally, you may evaluate how the addition of DocMorris to your portfolios can decrease your overall portfolio volatility.